BCR and neoplasm: In BRCA, TP53 mutations are correlated to higher tumor-infiltrating lymphocyte (TIL) fraction, higher interferon gamma, higher macrophage, and higher B cell receptor (BCR) richness and diversity (S5 Table), which is consistent with previous results that TP53 mutations may promote immunogenic activity in BRCA.